Patent 6875432 was granted and assigned to Genentech on April, 2005 by the United States Patent and Trademark Office.
The present application concerns concentrated protein formulations with reduced viscosity, which are particularly suitable for subcutaneous administration. The application further concerns a method for reducing the viscosity of concentrated protein formulations.